Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of Osteogenic Phenotype in Postmenopausal Women Receiving Anabolic and Antiresorptive Osteoporosis Therapies.

Endocrinology - 30 Oct 2024

Kobelski Margaret M, Ramchand Sabashini K, Tsai Joy N, Leder Benjamin Z, Demay Marie B

Abstract excerpt

Aging of the general population has led to a substantial increase in the prevalence of osteoporosis over the past decades. While there are effective pharmacological agents that increase bone formation, decrease bone resorption, and decrease fracture risk, they do not uniformly cure osteoporosis. This has prompted investigations to examine whether combination therapy (COMBO) with these agents can result in an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Bone Density Conservation Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Mesenchymal Stem Cells

Share to Osteogenesis

Share to Osteoporosis, Postmenopausal

Share to Postmenopause

Share to Receptors, G-Protein-Coupled

Source

Open in PubMed Open full text

Identifiers

PMID: 39445778
DOI: 10.1210/endocr/bqae142
PMCID: PMC11523613

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Osteogenic Phenotype in Postmenopausal Women Receiving Anabolic and Antiresorptive Osteoporosis Therapies.PMID 39445778Read ↗

Evaluation of Osteolforte on Bone Marrow Stromal Cells (BMSC): A Study on Cell Viability, Osteogenic Differentiation, and Gene ExpressionSemantic proximity Read ↗

Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosisSemantic proximity Read ↗

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response.Semantic proximity Read ↗

Effects of a mixture of growth factors and proteins on the development of the osteogenic phenotype in human alveolar bone cell cultures.Semantic proximity Read ↗

SP500263, a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSF.Semantic proximity Read ↗

Hemopoietic functions of marrow-derived osteogenic cells.Semantic proximity Read ↗

Genistein Promotion of Osteogenic Differentiation through BMP2/SMAD5/RUNX2 SignalingSemantic proximity Read ↗

Properties of human trabecular bone cells from elderly women: implications for cell-based bone engraftment.Semantic proximity Read ↗

Osteogenic protein-1 enhances phenotypic expression in ROS 17/2.8 cells.Semantic proximity Read ↗

The effect of gabapentin-lactam hydroxamic acid derivatives on ovine osteoblast proliferation and phenotype: perspectives for tissue engineering application.Semantic proximity Read ↗

Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unionsSemantic proximity Read ↗

Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarraySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.